2010年～2013年新疆某院住院患者恶性肿瘤疾病构成分析

目的 分析2010年-2013年新疆某院住院患者恶性肿瘤疾病构成及变化趋势,为掌握新疆肿瘤流行情况及防治提供参考.方法 回顾统计2010年-2013年新疆某院恶性肿瘤住院患者的基本资料.通过Microsoft Excel软件和spssl7.0统计软件对恶性肿瘤顺位、性别、民族、构成进行统计分析.结果 前十位的恶性肿瘤分别为：乳腺癌、肺癌、宫颈癌、胃癌、食管癌、甲状腺癌、肝癌、直肠癌、卵巢癌和结肠癌,占住院恶性肿瘤的71.9％.4年间,前十位病种顺位无变化,各恶性肿瘤疾病男女性别构成差异较大,男性患胃癌、肝癌、食管癌、肺癌比例高于女性.食管癌和胃癌在60岁-69岁间的发病率最高,肺癌在70岁-79岁间的发病率最高.乳腺癌和宫颈癌在40岁-49岁间的发病率最高.结论 新疆具有独特的地域特征,恶性肿瘤患者的疾病谱与全国有所不同,应根据当地的恶性肿瘤分布特征制定适宜的预防措施.

Disease Composition Analysis on Malignant Tumor Inpatients in a Hospital of Xinjiang from 2010 to 2013

Objectives To analyze the disease composition and change tendency of malignant tumor inpatients in a hospital of Xinjiang from 2010 to 2013, and provide reference for the grasp of epidemic characters and prevention of tumor diseases in Xinjiang. Methods A retrospective statistic analysis was conducted on the basic information of malignant tumor inpatients in a hospital of Xinjiang from 2010 to 2013, then analyzed,the syn-position, gender, nationality, and disease composition with Microsoft Excel software and SPSS 17.0 statistical software. Results The top ten malignant tumors which accot~nting for 71.9% of the total inpatients with malignant tumor were respectively breast cancer, lung cancer, cervical cancer, stomach cancer, esophageal cancer, thyroid carcinoma, liver cancer, rectum cancer, ovarian cancer and colon cancer. The syn-position of the top ten malignant tumors remained stable within the four years. The difference between male and female in tumor disease composition was significant, men were more likely to have the stomach cancer, liver cancer, esophageal cancer and lung cancer than women, the high-risk age group of stomach cancer and esophageal cancer was 60-69 years old while 70-79 years old in lung cancer and 40-49 years old in breast cancer and cervical cancer. Conclusions Xinjiang has the special regional style and characteristics, so the spectrum of disease was different from the national wide. It is necessary to make suitable prevention and treatment measures based on the distribution of the malignant tumor patients.